EMOR (Healixa) Cash-to-Debt: 0.00 (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Healixa Cash-to-Debt?

Healixa EMOR Cash-to-Debt is 0.00 as of . 20.

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Healixa's cash to debt ratio for the quarter that ended in . 20 was 0.00.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Healixa couldn't pay off its debt using the cash in hand for the quarter that ended in . 20.

The historical rank and industry rank for Healixa's Cash-to-Debt or its related term are showing as below:

EMOR's Cash-to-Debt is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 0.78
* Ranked among companies with meaningful Cash-to-Debt only.

Healixa  (OTCPK:EMOR) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Healixa Cash-to-Debt Related Terms

Healixa Cash-to-Debt Historical Data

* Premium members only.

The historical data trend for Healixa's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Healixa Cash-to-Debt Chart

Healixa Annual Data
Trend
Cash-to-Debt

Healixa Quarterly Data
Cash-to-Debt

Healixa Cash-to-Debt Competitor Comparison

For the Health Information Services subindustry, Healixa's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Healixa Cash-to-Debt vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Healixa's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Healixa's Cash-to-Debt falls into.


Healixa Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Healixa's Cash to Debt Ratio for the fiscal year that ended in . 20 is calculated as:

Do not have enough data to calculate Cash to Debt ratio.

Healixa's Cash to Debt Ratio for the quarter that ended in . 20 is calculated as:

Do not have enough data to calculate Cash to Debt ratio.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Cash-to-Debt →
What does a Cash-to-Debt of 0.00 mean?
Healixa (EMOR) has a Cash-to-Debt of 0.00 as of . 20.
Is Healixa's Cash-to-Debt too high?
Healixa's current Cash-to-Debt is 0.00.
How does Healixa's Cash-to-Debt compare to competitors?
Healixa's Cash-to-Debt of 0.00 can be compared against companies in the Healthcare Providers & Services industry. The industry median Cash-to-Debt is 0.78. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash-to-Debt for a Healthcare Providers & Services company?
The median Cash-to-Debt among Healthcare Providers & Services companies is 0.78, based on 673 companies in the industry. Companies in the top quartile (top 25%) have a Cash-to-Debt significantly above this median, while those in the bottom quartile fall well below. However, Cash-to-Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash-to-Debt mean?
A high Cash-to-Debt can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median Cash-to-Debt is 0.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Healixa's current Cash-to-Debt is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Healixa stock overvalued right now?
Healixa (EMOR) has a current Cash-to-Debt of 0.00. The current Cash-to-Debt is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash-to-Debt calculated?
Cash-to-Debt is calculated from a company's financial statements. For Healixa (EMOR), the current Cash-to-Debt is 0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Healixa Business Description

Address 273 Knickerbocker Avenue, Bohemia, New York, NY, USA, 11716
Healixa Inc is a technology company focused on building and acquiring disruptive technologies in the health-tech, clean water harvesting, and green-tech industries. Its activities consist mainly of research and development, intellectual property development, engineering validation, pilot deployment, and early-stage commercialization of its technology platforms. The company also focuses on clean water through its Eternal Spring Deposition Water Harvesting technology and on water harvesting and thermal cooling technologies.